TANG CAPITAL MANAGEMENT LLC 13D and 13G filings for Aurinia Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-04 5:04 pm Purchase |
2025-02-28 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
TANG CAPITAL MANAGEMENT LLC | 10,029,500 7.300% |
2,800,000 (+38.73%) |
Filing |
| 2024-09-12 4:10 pm Purchase |
2024-09-06 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
TANG CAPITAL MANAGEMENT LLC | 7,229,500 5.100% |
7,229,500 (New Position) |
Filing |